Catalyst Wire Dossier Catalyst Wire Dossier

FlutiForm HFA MDI 100/10 µg

fluticasone propionate/formoterol · SkyePharma AG
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for FlutiForm HFA MDI 100/10 µg, covering 2011-06-23 to 2011-06-23. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma [Phase 3]

See pricing